Hypertension-induced cardiac impairment is reversed by the inhibition of endoplasmic reticulum stress.

These results suggest that ERS inhibition may ameliorate cardiac contractility through improving ERS-associated calcium mishandling, apoptosis, inflammation and fibrosis, thereby offering therapeutic potential in hypertension-induced cardiac dysfunction.